CEPHALEXIN

Product NDC: 63304-958
11-digit product format: 633040958
Labeler code: 63304
Product ID: 63304-958_6db14b9b-5e94-4cd5-9d7b-cdf97d383648
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: CEPHALEXIN
Dosage form: SUSPENSION
Route: ORAL
Labeler: Ranbaxy Pharmaceuticals Inc.
Application: ANDA065081
Marketing category: ANDA
Marketing start: 2001-10-29
Marketing end: 0000-00-00
Substance: CEPHALEXIN
Active strength: 125 mg/5mL
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	63304-958		I	Inactivated by FDA	2026-10-12
excluded package	package	63304-958	63304-958-01	I	Inactivated by FDA	2026-10-12
excluded package	package	63304-958	63304-958-02	I	Inactivated by FDA	2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 66 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63304-958-02	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63304-958-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63304-958-02	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63304-958-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63304-958-02	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63304-958-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63304-958-02	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63304-958-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63304-958-02	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63304-958-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63304-958-02	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63304-958-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63304-958-02	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63304-958-01	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63304-958-02	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63304-958-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63304-958-02	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63304-958-01	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63304-958-02	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63304-958-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63304-958-02	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63304-958-01	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63304-958-02	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63304-958-01	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	63304-958-02	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	63304-958-01	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	63304-958-02	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	63304-958-01	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	63304-958-02	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	63304-958-01	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	63304-958-02	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	63304-958-01	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	63304-958-02	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	63304-958-01	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	63304-958-02	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	63304-958-01	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	63304-958-02	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	63304-958-01	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	63304-958-02	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	63304-958-01	`e2bbac7714bc…`	`27bdfed8d636…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A065081-001	CEPHALEXIN	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL			2001-07-27
A065081-002	CEPHALEXIN	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL			2001-07-27

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A065081-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A065081-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A065081-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065081-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A065081-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065081-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065081-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065081-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065081-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065081-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065081-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065081-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065081-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065081-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065081-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065081-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065081-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065081-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065081-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065081-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065081-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065081-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065081-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065081-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065081-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065081-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065081-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065081-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065081-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065081-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065081-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A065081-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065081-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065081-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065081-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065081-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065081-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065081-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065081-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065081-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	2001-07-27	`74a2ff9319b5…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
dfa3f520-409c-432e-b6d3-9250d468c772	Product name	1	20250401
64bb7f1a-2c2e-4741-8301-dbfeda7239f6	Product name	1	20190628
398aa563-bb78-fe0f-46a8-757c40ef28bf	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
63304-958-01	2019-11-13	C162847	48780-1	97449f38-cb45-f6ea-e053-dbdaa90aa703	CEPHALEXIN CAPSULES, USP AND CEPHALEXIN FOR ORAL SUSPENSION, USP Rx only
63304-958-02	2019-11-13	C162847	48780-1	97449f38-cb45-f6ea-e053-dbdaa90aa703	CEPHALEXIN CAPSULES, USP AND CEPHALEXIN FOR ORAL SUSPENSION, USP Rx only

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
63304-958-01	CEPHALEXIN	100 mL in 1 BOTTLE	SUSPENSION	100		2
63304-958-02	CEPHALEXIN	200 mL in 1 BOTTLE	SUSPENSION	200		2

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
63304-958-01	ML - Milliliter	63304-958	4e7a2157-3454-4f8d-8839-3179217576cf	1	2013-02-13
63304-958-02	ML - Milliliter	63304-958	16ba5d92-cec8-4daf-9fdc-f31513a5342d	1	2013-02-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
cephalexin	ACTIVE INGREDIENT	OBN7UDS42Y	CEPHALEXIN (CEPHALEXIN) CAPSULE CEPHALEXIN (CEPHALEXIN) SUSPENSION [RANBAXY PHARMACEUTICALS INC.]	1
CEPHALEXIN	ACTIVE INGREDIENT	OBN7UDS42Y	CEPHALEXIN SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1
CEPHALEXIN ANHYDROUS	ACTIVE MOIETY	5SFF1W6677	CEPHALEXIN SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1
cephalexin anhydrous	ACTIVE MOIETY	5SFF1W6677	CEPHALEXIN (CEPHALEXIN) CAPSULE CEPHALEXIN (CEPHALEXIN) SUSPENSION [RANBAXY PHARMACEUTICALS INC.]	1
colloidal silicon dioxide	INACTIVE INGREDIENT	ETJ7Z6XBU4	CEPHALEXIN (CEPHALEXIN) CAPSULE CEPHALEXIN (CEPHALEXIN) SUSPENSION [RANBAXY PHARMACEUTICALS INC.]	1
D&C yellow no. 10	INACTIVE INGREDIENT		CEPHALEXIN (CEPHALEXIN) CAPSULE CEPHALEXIN (CEPHALEXIN) SUSPENSION [RANBAXY PHARMACEUTICALS INC.]	1
edible printing ink with black iron oxide	INACTIVE INGREDIENT		CEPHALEXIN (CEPHALEXIN) CAPSULE CEPHALEXIN (CEPHALEXIN) SUSPENSION [RANBAXY PHARMACEUTICALS INC.]	1
FD&C blue no.1	INACTIVE INGREDIENT		CEPHALEXIN (CEPHALEXIN) CAPSULE CEPHALEXIN (CEPHALEXIN) SUSPENSION [RANBAXY PHARMACEUTICALS INC.]	1
FD&C green no. 3	INACTIVE INGREDIENT		CEPHALEXIN (CEPHALEXIN) CAPSULE CEPHALEXIN (CEPHALEXIN) SUSPENSION [RANBAXY PHARMACEUTICALS INC.]	1
FD&C red no. 40	INACTIVE INGREDIENT		CEPHALEXIN (CEPHALEXIN) CAPSULE CEPHALEXIN (CEPHALEXIN) SUSPENSION [RANBAXY PHARMACEUTICALS INC.]	1
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	CEPHALEXIN SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1
FD&C yellow no. 6	INACTIVE INGREDIENT		CEPHALEXIN (CEPHALEXIN) CAPSULE CEPHALEXIN (CEPHALEXIN) SUSPENSION [RANBAXY PHARMACEUTICALS INC.]	1
gelatin	INACTIVE INGREDIENT	2G86QN327L	CEPHALEXIN (CEPHALEXIN) CAPSULE CEPHALEXIN (CEPHALEXIN) SUSPENSION [RANBAXY PHARMACEUTICALS INC.]	1
lactose monohydrate	INACTIVE INGREDIENT	EWQ57Q8I5X	CEPHALEXIN (CEPHALEXIN) CAPSULE CEPHALEXIN (CEPHALEXIN) SUSPENSION [RANBAXY PHARMACEUTICALS INC.]	1
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	CEPHALEXIN (CEPHALEXIN) CAPSULE CEPHALEXIN (CEPHALEXIN) SUSPENSION [RANBAXY PHARMACEUTICALS INC.]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CEPHALEXIN SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	CEPHALEXIN SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1
sodium benzoate	INACTIVE INGREDIENT	OJ245FE5EU	CEPHALEXIN (CEPHALEXIN) CAPSULE CEPHALEXIN (CEPHALEXIN) SUSPENSION [RANBAXY PHARMACEUTICALS INC.]	1
strawberry flavor	INACTIVE INGREDIENT		CEPHALEXIN (CEPHALEXIN) CAPSULE CEPHALEXIN (CEPHALEXIN) SUSPENSION [RANBAXY PHARMACEUTICALS INC.]	1
sucrose	INACTIVE INGREDIENT	C151H8M554	CEPHALEXIN (CEPHALEXIN) CAPSULE CEPHALEXIN (CEPHALEXIN) SUSPENSION [RANBAXY PHARMACEUTICALS INC.]	1
SUCROSE	INACTIVE INGREDIENT	C151H8M554	CEPHALEXIN SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	CEPHALEXIN (CEPHALEXIN) CAPSULE CEPHALEXIN (CEPHALEXIN) SUSPENSION [RANBAXY PHARMACEUTICALS INC.]	1
xanthan gum	INACTIVE INGREDIENT		CEPHALEXIN (CEPHALEXIN) CAPSULE CEPHALEXIN (CEPHALEXIN) SUSPENSION [RANBAXY PHARMACEUTICALS INC.]	1
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	CEPHALEXIN SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
63304-958	CEPHALEXIN CAPSULE CEPHALEXIN SUSPENSION [RANBAXY PHARMACEUTICALS INC.]	2	Legacy NDC, 2 package rows	20181010_5681d4d2-9b67-4cac-9b94-8368f9978231.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
OBN7UDS42Y	CEPHALEXIN	23325-78-2	CEPHALEXIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
309110	cephalexin 125 MG in 5 mL Oral Suspension	PSN	5681d4d2-9b67-4cac-9b94-8368f9978231	2
309113	cephalexin 250 MG in 5 mL Oral Suspension	PSN	5681d4d2-9b67-4cac-9b94-8368f9978231	2
309112	cephalexin 250 MG Oral Capsule	PSN	5681d4d2-9b67-4cac-9b94-8368f9978231	2
309114	cephalexin 500 MG Oral Capsule	PSN	5681d4d2-9b67-4cac-9b94-8368f9978231	2
309110	cephalexin 25 MG/ML Oral Suspension	SCD	5681d4d2-9b67-4cac-9b94-8368f9978231	2
309112	cephalexin 250 MG Oral Capsule	SCD	5681d4d2-9b67-4cac-9b94-8368f9978231	2
309113	cephalexin 50 MG/ML Oral Suspension	SCD	5681d4d2-9b67-4cac-9b94-8368f9978231	2
309114	cephalexin 500 MG Oral Capsule	SCD	5681d4d2-9b67-4cac-9b94-8368f9978231	2
309114	cefalexin (as cefalexin monohydrate) 500 MG Oral Capsule	SY	5681d4d2-9b67-4cac-9b94-8368f9978231	2
309110	cefalexin 25 MG/ML Oral Suspension	SY	5681d4d2-9b67-4cac-9b94-8368f9978231	2
309113	cefalexin 50 MG/ML Oral Suspension	SY	5681d4d2-9b67-4cac-9b94-8368f9978231	2
309112	cephalexin (as cephalexin monohydrate) 250 MG Oral Capsule	SY	5681d4d2-9b67-4cac-9b94-8368f9978231	2
309110	cephalexin 125 MG per 5 ML Oral Suspension	SY	5681d4d2-9b67-4cac-9b94-8368f9978231	2
309113	cephalexin 250 MG per 5 ML Oral Suspension	SY	5681d4d2-9b67-4cac-9b94-8368f9978231	2
309110	cephalexin 125 MG in 5 mL Oral Suspension	PSN	d9a049bd-2161-4a9b-8f6d-0c7d2bfdb0ed	1
309113	cephalexin 250 MG in 5 mL Oral Suspension	PSN	d9a049bd-2161-4a9b-8f6d-0c7d2bfdb0ed	1
309110	cephalexin 25 MG/ML Oral Suspension	SCD	d9a049bd-2161-4a9b-8f6d-0c7d2bfdb0ed	1
309113	cephalexin 50 MG/ML Oral Suspension	SCD	d9a049bd-2161-4a9b-8f6d-0c7d2bfdb0ed	1
309110	cefalexin 25 MG/ML Oral Suspension	SY	d9a049bd-2161-4a9b-8f6d-0c7d2bfdb0ed	1
309113	cefalexin 50 MG/ML Oral Suspension	SY	d9a049bd-2161-4a9b-8f6d-0c7d2bfdb0ed	1
309110	cephalexin 125 MG per 5 ML Oral Suspension	SY	d9a049bd-2161-4a9b-8f6d-0c7d2bfdb0ed	1
309113	cephalexin 250 MG per 5 ML Oral Suspension	SY	d9a049bd-2161-4a9b-8f6d-0c7d2bfdb0ed	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
63304-958-01	63304095801	100 mL in 1 BOTTLE	100 ml	Historical
63304-958-02	63304095802	200 mL in 1 BOTTLE	200 ml	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
CEPHALEXIN CAPSULES, USP AND CEPHALEXIN FOR ORAL SUSPENSION, USP Rx only	Ranbaxy Pharmaceuticals Inc. \| Ranbaxy Laboratories Limited	2011-08-29	HUMAN PRESCRIPTION DRUG LABEL	2
Cephalexin - Physicians Total Care, Inc.	Physicians Total Care, Inc.	2010-03-10	HUMAN PRESCRIPTION DRUG LABEL	1